PharmaRoth Labs (PharmaRoth Labs) EV-to-EBITDA : 0.00 (As of May. 21, 2024)

PharmaRoth Labs EV-to-EBITDA Chart

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EV-to-EBITDA	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of PharmaRoth Labs's EV-to-EBITDA

For the Biotechnology subindustry, PharmaRoth Labs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaRoth Labs's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's EV-to-EBITDA falls into.

PharmaRoth Labs EV-to-EBITDA Calculation

PharmaRoth Labs's EV-to-EBITDA for today is calculated as:

PharmaRoth Labs's current Enterprise Value is $0.00 Mil.
PharmaRoth Labs's EBITDA for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaRoth Labs  (GREY:ROTH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PharmaRoth Labs's PE Ratio for today is calculated as:

PharmaRoth Labs's share price for today is $0.0001.
PharmaRoth Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

PharmaRoth Labs EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description